NCT02413801View on ClinicalTrials.gov

Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

March 19, 2015

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Psoriasis
Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
collaborator

Rheumatology Research Foundation

OTHER

lead

University of Rochester

OTHER

NCT02413801 - Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients | Biotech Hunter | Biotech Hunter